FDA Grants Amgen Priority Review for Kyprolis® (Carfilzomib) Supplemental New Drug Application for the Treatment of …

| March 30, 2015 | 0 Comments

THOUSAND OAKS, Calif., March 30, 2015 /PRNewswire/ — Amgen (AMGN) today announced that the U.S.

Continued here:
FDA Grants Amgen Priority Review for Kyprolis® (Carfilzomib) Supplemental New Drug Application for the Treatment of …

Tags: , , , , , , ,

Category: Recent News

About the Author ()

Leave a Reply